BRCA2-IN-2

• Description :

  BRCA2-IN-2 (Compound 3i) has a strong binding affinity to the BRCA2 protein. BRCA2-IN-2 can inhibit the proliferation of breast cancer cells and scavenge DPPH free radicals. BRCA2-IN-2 has anti-tumor and antioxidant activities[1].

• UNSPSC :

  12352211

• Target :

  Reactive Oxygen Species (ROS)

• Related Pathways :

  Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Cancer; Inflammation/Immunology

• Smiles :

  NS(=O)(C1=CC=C(C=C1)/N=N/C2=CC=C(C(/C=N/C3=NC=CC=C3)=C2)O)=O

• Molecular Formula :

  C18H15N5O3S

• Molecular Weight :

  381.41

• References & Citations :

  [1]Rezaeianzadeh O, et al. Synthesis and application of diazenyl sulfonamide-based schiff bases as potential BRCA2 active inhibitors against MCF-7 breast cancer cell line. Sci Rep. 2025 Feb 24;15 (1) :6661.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported